COPD薬の世界市場:メーカー別、地域別、種類別、用途別、市場予測(~2023)

【英語タイトル】Global COPD Drugs Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

GlobalInfoResearchが出版した調査資料(GIR8101467)・商品コード:GIR8101467
・発行会社(調査会社):GlobalInfoResearch
・発行日:2018年10月17日(※2024年版があります。お問い合わせください)
・ページ数:134
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・調査対象地域:世界
・産業分野:医療・バイオ
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,480 ⇒換算¥515,040見積依頼/購入/質問フォーム
Multi User(10名様閲覧用)USD5,220 ⇒換算¥772,560見積依頼/購入/質問フォーム
Corporate User(同一法人内共有可)USD6,960 ⇒換算¥1,030,080見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本調査レポートは、COPD薬の世界市場について調べ、まとめました。種類別セグメントは、気管支拡張薬、PDE-4阻害剤、ステロイド、併用療法、その他等、用途別セグメントは、病院、診療所、その他等に区分しました。COPD薬の世界市場概観、メーカー動向、メーカー別COPD薬シェア、市場規模推移、市場規模予測、主要地域分析(北米、ヨーロッパ、アジア等)、主要国分析(日本、中国、アメリカ等)データなどの情報が含まれています。
・COPD薬の市場概観
・COPD薬のメーカー概要(事業概要、製品種類、価格、売上、市場シェア等)
・COPD薬のメーカー別販売動向、市場シェア、市場集中度、競争動向
・COPD薬の世界市場規模
・COPD薬の北米市場分析(アメリカ、カナダ、メキシコ等)
・COPD薬のアメリカ市場規模推移
・COPD薬のカナダ市場規模推移
・COPD薬のメキシコ市場規模推移
・COPD薬のヨーロッパ市場分析(ドイツ、イギリス、ロシア、フランス、イタリア等)
・COPD薬のドイツ市場規模推移
・COPD薬のイギリス市場規模推移
・COPD薬のロシア市場規模推移
・COPD薬のアジア市場分析(日本、中国、韓国、インド、東南アジア等)
・COPD薬の日本市場規模推移
・COPD薬の中国市場規模推移
・COPD薬の韓国市場規模推移
・COPD薬のインド市場規模推移
・COPD薬の東南アジア市場規模推移
・COPD薬の南米市場分析(ブラジル、アルゼンチン等)
・COPD薬の中東・アフリカ市場分析(サウジアラビア、UAE、南アフリカ等)
・COPD薬の種類別分析/市場規模推移(気管支拡張薬、PDE-4阻害剤、ステロイド、併用療法、その他)
・COPD薬の用途別分析/市場規模推移(病院、診療所、その他)
・COPD薬の市場予測(地域別予測、種類別予測、用途別予測)
・COPD薬の販売チャネル・代理店・貿易業者・ディーラー分析
【レポートの概要】

COPD drugs is a medicine used to treatment chronic obstructive pulmonary disease, such as bronchodilators, pde-4 inhibitors, steroids, combination therapies, etc.

Scope of the Report:

This report studies the COPD Drugs market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the COPD Drugs market by product type and applications/end industries.

One of the emerging trends propelling the growth prospects for this market is the augmented focus and use of combination therapies to treat COPD. Combination therapies are increasingly becoming the preferred choice of treatment as they have better efficacy than monotherapy drugs.

The bronchodilators segment is one of the fastest growing segments of the COPD drugs market. Bronchodilators help relax bronchial muscles resulting in normal breathing. These drugs can be categorized into three types, namely beta-sympathomimetic, anticholinergics, and xanthine derivatives.

The global COPD Drugs market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of COPD Drugs.

Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

Market Segment by Companies, this report covers

Pfizer

Novartis

GlaxoSmithKline

Merck

Abbott Laboratories

Boehringer Ingelheim

AstraZeneca

Roche Holding AG

Teva Pharmaceutical Industries

Vectura Group

Mylan NV

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Bronchodilators

PDE-4 Inhibitors

Steroids

Combination Therapies

Others

Market Segment by Applications, can be divided into

Hospitals

Clinics

Others

【レポートの目次】

Table of Contents

1 COPD Drugs Market Overview

1.1 Product Overview and Scope of COPD Drugs

1.2 Classification of COPD Drugs by Types

1.2.1 Global COPD Drugs Revenue Comparison by Types (2017-2023)

1.2.2 Global COPD Drugs Revenue Market Share by Types in 2017

1.2.3 Bronchodilators

1.2.4 PDE-4 Inhibitors

1.2.5 Steroids

1.2.6 Combination Therapies

1.2.7 Others

1.3 Global COPD Drugs Market by Application

1.3.1 Global COPD Drugs Market Size and Market Share Comparison by Applications (2013-2023)

1.3.2 Hospitals

1.3.3 Clinics

1.3.4 Others

1.4 Global COPD Drugs Market by Regions

1.4.1 Global COPD Drugs Market Size (Million USD) Comparison by Regions (2013-2023)

1.4.1 North America (USA, Canada and Mexico) COPD Drugs Status and Prospect (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy) COPD Drugs Status and Prospect (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) COPD Drugs Status and Prospect (2013-2023)

1.4.4 South America (Brazil, Argentina, Colombia) COPD Drugs Status and Prospect (2013-2023)

1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) COPD Drugs Status and Prospect (2013-2023)

1.5 Global Market Size of COPD Drugs (2013-2023)

2 Manufacturers Profiles

2.1 Pfizer

2.1.1 Business Overview

2.1.2 COPD Drugs Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Pfizer COPD Drugs Revenue, Gross Margin and Market Share (2016-2017)

2.2 Novartis

2.2.1 Business Overview

2.2.2 COPD Drugs Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Novartis COPD Drugs Revenue, Gross Margin and Market Share (2016-2017)

2.3 GlaxoSmithKline

2.3.1 Business Overview

2.3.2 COPD Drugs Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 GlaxoSmithKline COPD Drugs Revenue, Gross Margin and Market Share (2016-2017)

2.4 Merck

2.4.1 Business Overview

2.4.2 COPD Drugs Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Merck COPD Drugs Revenue, Gross Margin and Market Share (2016-2017)

2.5 Abbott Laboratories

2.5.1 Business Overview

2.5.2 COPD Drugs Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Abbott Laboratories COPD Drugs Revenue, Gross Margin and Market Share (2016-2017)

2.6 Boehringer Ingelheim

2.6.1 Business Overview

2.6.2 COPD Drugs Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Boehringer Ingelheim COPD Drugs Revenue, Gross Margin and Market Share (2016-2017)

2.7 AstraZeneca

2.7.1 Business Overview

2.7.2 COPD Drugs Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 AstraZeneca COPD Drugs Revenue, Gross Margin and Market Share (2016-2017)

2.8 Roche Holding AG

2.8.1 Business Overview

2.8.2 COPD Drugs Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 Roche Holding AG COPD Drugs Revenue, Gross Margin and Market Share (2016-2017)

2.9 Teva Pharmaceutical Industries

2.9.1 Business Overview

2.9.2 COPD Drugs Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 Teva Pharmaceutical Industries COPD Drugs Revenue, Gross Margin and Market Share (2016-2017)

2.10 Vectura Group

2.10.1 Business Overview

2.10.2 COPD Drugs Type and Applications

2.10.2.1 Product A

2.10.2.2 Product B

2.10.3 Vectura Group COPD Drugs Revenue, Gross Margin and Market Share (2016-2017)

2.11 Mylan NV

2.11.1 Business Overview

2.11.2 COPD Drugs Type and Applications

2.11.2.1 Product A

2.11.2.2 Product B

2.11.3 Mylan NV COPD Drugs Revenue, Gross Margin and Market Share (2016-2017)

3 Global COPD Drugs Market Competition, by Players

3.1 Global COPD Drugs Revenue and Share by Players (2013-2018)

3.2 Market Concentration Rate

3.2.1 Top 5 COPD Drugs Players Market Share

3.2.2 Top 10 COPD Drugs Players Market Share

3.3 Market Competition Trend

4 Global COPD Drugs Market Size by Regions

4.1 Global COPD Drugs Revenue and Market Share by Regions

4.2 North America COPD Drugs Revenue and Growth Rate (2013-2018)

4.3 Europe COPD Drugs Revenue and Growth Rate (2013-2018)

4.4 Asia-Pacific COPD Drugs Revenue and Growth Rate (2013-2018)

4.5 South America COPD Drugs Revenue and Growth Rate (2013-2018)

4.6 Middle East and Africa COPD Drugs Revenue and Growth Rate (2013-2018)

5 North America COPD Drugs Revenue by Countries

5.1 North America COPD Drugs Revenue by Countries (2013-2018)

5.2 USA COPD Drugs Revenue and Growth Rate (2013-2018)

5.3 Canada COPD Drugs Revenue and Growth Rate (2013-2018)

5.4 Mexico COPD Drugs Revenue and Growth Rate (2013-2018)

6 Europe COPD Drugs Revenue by Countries

6.1 Europe COPD Drugs Revenue by Countries (2013-2018)

6.2 Germany COPD Drugs Revenue and Growth Rate (2013-2018)

6.3 UK COPD Drugs Revenue and Growth Rate (2013-2018)

6.4 France COPD Drugs Revenue and Growth Rate (2013-2018)

6.5 Russia COPD Drugs Revenue and Growth Rate (2013-2018)

6.6 Italy COPD Drugs Revenue and Growth Rate (2013-2018)

7 Asia-Pacific COPD Drugs Revenue by Countries

7.1 Asia-Pacific COPD Drugs Revenue by Countries (2013-2018)

7.2 China COPD Drugs Revenue and Growth Rate (2013-2018)

7.3 Japan COPD Drugs Revenue and Growth Rate (2013-2018)

7.4 Korea COPD Drugs Revenue and Growth Rate (2013-2018)

7.5 India COPD Drugs Revenue and Growth Rate (2013-2018)

7.6 Southeast Asia COPD Drugs Revenue and Growth Rate (2013-2018)

8 South America COPD Drugs Revenue by Countries

8.1 South America COPD Drugs Revenue by Countries (2013-2018)

8.2 Brazil COPD Drugs Revenue and Growth Rate (2013-2018)

8.3 Argentina COPD Drugs Revenue and Growth Rate (2013-2018)

8.4 Colombia COPD Drugs Revenue and Growth Rate (2013-2018)

9 Middle East and Africa Revenue COPD Drugs by Countries

9.1 Middle East and Africa COPD Drugs Revenue by Countries (2013-2018)

9.2 Saudi Arabia COPD Drugs Revenue and Growth Rate (2013-2018)

9.3 UAE COPD Drugs Revenue and Growth Rate (2013-2018)

9.4 Egypt COPD Drugs Revenue and Growth Rate (2013-2018)

9.5 Nigeria COPD Drugs Revenue and Growth Rate (2013-2018)

9.6 South Africa COPD Drugs Revenue and Growth Rate (2013-2018)

10 Global COPD Drugs Market Segment by Type

10.1 Global COPD Drugs Revenue and Market Share by Type (2013-2018)

10.2 Global COPD Drugs Market Forecast by Type (2018-2023)

10.3 Bronchodilators Revenue Growth Rate (2013-2023)

10.4 PDE-4 Inhibitors Revenue Growth Rate (2013-2023)

10.5 Steroids Revenue Growth Rate (2013-2023)

10.6 Combination Therapies Revenue Growth Rate (2013-2023)

10.7 Others Revenue Growth Rate (2013-2023)

11 Global COPD Drugs Market Segment by Application

11.1 Global COPD Drugs Revenue Market Share by Application (2013-2018)

11.2 COPD Drugs Market Forecast by Application (2018-2023)

11.3 Hospitals Revenue Growth (2013-2018)

11.4 Clinics Revenue Growth (2013-2018)

11.5 Others Revenue Growth (2013-2018)

12 Global COPD Drugs Market Size Forecast (2018-2023)

12.1 Global COPD Drugs Market Size Forecast (2018-2023)

12.2 Global COPD Drugs Market Forecast by Regions (2018-2023)

12.3 North America COPD Drugs Revenue Market Forecast (2018-2023)

12.4 Europe COPD Drugs Revenue Market Forecast (2018-2023)

12.5 Asia-Pacific COPD Drugs Revenue Market Forecast (2018-2023)

12.6 South America COPD Drugs Revenue Market Forecast (2018-2023)

12.7 Middle East and Africa COPD Drugs Revenue Market Forecast (2018-2023)

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Data Source

List of Tables and Figures



Figure COPD Drugs Picture

Table Product Specifications of COPD Drugs

Table Global COPD Drugs and Revenue (Million USD) Market Split by Product Type

Figure Global COPD Drugs Revenue Market Share by Types in 2017

Figure Bronchodilators Picture

Figure PDE-4 Inhibitors Picture

Figure Steroids Picture

Figure Combination Therapies Picture

Figure Others Picture

Table Global COPD Drugs Revenue (Million USD) by Application (2013-2023)

Figure COPD Drugs Revenue Market Share by Applications in 2017

Figure Hospitals Picture

Figure Clinics Picture

Figure Others Picture

Table Global Market COPD Drugs Revenue (Million USD) Comparison by Regions 2013-2023

Figure North America COPD Drugs Revenue (Million USD) and Growth Rate (2013-2023)

Figure Europe COPD Drugs Revenue (Million USD) and Growth Rate (2013-2023)

Figure Asia-Pacific COPD Drugs Revenue (Million USD) and Growth Rate (2013-2023)

Figure South America COPD Drugs Revenue (Million USD) and Growth Rate (2013-2023)

Figure Middle East and Africa COPD Drugs Revenue (Million USD) and Growth Rate (2013-2023)

Figure Global COPD Drugs Revenue (Million USD) and Growth Rate (2013-2023)

Table Pfizer Basic Information, Manufacturing Base and Competitors

Table Pfizer COPD Drugs Type and Applications

Table Pfizer COPD Drugs Revenue, Gross Margin and Market Share (2016-2017)

Table Novartis Basic Information, Manufacturing Base and Competitors

Table Novartis COPD Drugs Type and Applications

Table Novartis COPD Drugs Revenue, Gross Margin and Market Share (2016-2017)

Table GlaxoSmithKline Basic Information, Manufacturing Base and Competitors

Table GlaxoSmithKline COPD Drugs Type and Applications

Table GlaxoSmithKline COPD Drugs Revenue, Gross Margin and Market Share (2016-2017)

Table Merck Basic Information, Manufacturing Base and Competitors

Table Merck COPD Drugs Type and Applications

Table Merck COPD Drugs Revenue, Gross Margin and Market Share (2016-2017)

Table Abbott Laboratories Basic Information, Manufacturing Base and Competitors

Table Abbott Laboratories COPD Drugs Type and Applications

Table Abbott Laboratories COPD Drugs Revenue, Gross Margin and Market Share (2016-2017)

Table Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors

Table Boehringer Ingelheim COPD Drugs Type and Applications

Table Boehringer Ingelheim COPD Drugs Revenue, Gross Margin and Market Share (2016-2017)

Table AstraZeneca Basic Information, Manufacturing Base and Competitors

Table AstraZeneca COPD Drugs Type and Applications

Table AstraZeneca COPD Drugs Revenue, Gross Margin and Market Share (2016-2017)

Table Roche Holding AG Basic Information, Manufacturing Base and Competitors

Table Roche Holding AG COPD Drugs Type and Applications

Table Roche Holding AG COPD Drugs Revenue, Gross Margin and Market Share (2016-2017)

Table Teva Pharmaceutical Industries Basic Information, Manufacturing Base and Competitors

Table Teva Pharmaceutical Industries COPD Drugs Type and Applications

Table Teva Pharmaceutical Industries COPD Drugs Revenue, Gross Margin and Market Share (2016-2017)

Table Vectura Group Basic Information, Manufacturing Base and Competitors

Table Vectura Group COPD Drugs Type and Applications

Table Vectura Group COPD Drugs Revenue, Gross Margin and Market Share (2016-2017)

Table Mylan NV Basic Information, Manufacturing Base and Competitors

Table Mylan NV COPD Drugs Type and Applications

Table Mylan NV COPD Drugs Revenue, Gross Margin and Market Share (2016-2017)

Table Global COPD Drugs Revenue (Million USD) by Players (2013-2018)

Table Global COPD Drugs Revenue Share by Players (2013-2018)

Figure Global COPD Drugs Revenue Share by Players in 2016

Figure Global COPD Drugs Revenue Share by Players in 2017

Figure Global Top 5 Players COPD Drugs Revenue Market Share in 2017

Figure Global Top 10 Players COPD Drugs Revenue Market Share in 2017

Figure Global COPD Drugs Revenue (Million USD) and Growth Rate (%) (2013-2018)

Table Global COPD Drugs Revenue (Million USD) by Regions (2013-2018)

Table Global COPD Drugs Revenue Market Share by Regions (2013-2018)

Figure Global COPD Drugs Revenue Market Share by Regions (2013-2018)

Figure Global COPD Drugs Revenue Market Share by Regions in 2017

Figure North America COPD Drugs Revenue and Growth Rate (2013-2018)

Figure Europe COPD Drugs Revenue and Growth Rate (2013-2018)

Figure Asia-Pacific COPD Drugs Revenue and Growth Rate (2013-2018)

Figure South America COPD Drugs Revenue and Growth Rate (2013-2018)

Figure Middle East and Africa COPD Drugs Revenue and Growth Rate (2013-2018)

Table North America COPD Drugs Revenue by Countries (2013-2018)

Table North America COPD Drugs Revenue Market Share by Countries (2013-2018)

Figure North America COPD Drugs Revenue Market Share by Countries (2013-2018)

Figure North America COPD Drugs Revenue Market Share by Countries in 2017

Figure USA COPD Drugs Revenue and Growth Rate (2013-2018)

Figure Canada COPD Drugs Revenue and Growth Rate (2013-2018)

Figure Mexico COPD Drugs Revenue and Growth Rate (2013-2018)

Table Europe COPD Drugs Revenue (Million USD) by Countries (2013-2018)

Figure Europe COPD Drugs Revenue Market Share by Countries (2013-2018)

Figure Europe COPD Drugs Revenue Market Share by Countries in 2017

Figure Germany COPD Drugs Revenue and Growth Rate (2013-2018)

Figure UK COPD Drugs Revenue and Growth Rate (2013-2018)

Figure France COPD Drugs Revenue and Growth Rate (2013-2018)

Figure Russia COPD Drugs Revenue and Growth Rate (2013-2018)

Figure Italy COPD Drugs Revenue and Growth Rate (2013-2018)

Table Asia-Pacific COPD Drugs Revenue (Million USD) by Countries (2013-2018)

Figure Asia-Pacific COPD Drugs Revenue Market Share by Countries (2013-2018)

Figure Asia-Pacific COPD Drugs Revenue Market Share by Countries in 2017

Figure China COPD Drugs Revenue and Growth Rate (2013-2018)

Figure Japan COPD Drugs Revenue and Growth Rate (2013-2018)

Figure Korea COPD Drugs Revenue and Growth Rate (2013-2018)

Figure India COPD Drugs Revenue and Growth Rate (2013-2018)

Figure Southeast Asia COPD Drugs Revenue and Growth Rate (2013-2018)

Table South America COPD Drugs Revenue by Countries (2013-2018)

Table South America COPD Drugs Revenue Market Share by Countries (2013-2018)

Figure South America COPD Drugs Revenue Market Share by Countries (2013-2018)

Figure South America COPD Drugs Revenue Market Share by Countries in 2017

Figure Brazil COPD Drugs Revenue and Growth Rate (2013-2018)

Figure Argentina COPD Drugs Revenue and Growth Rate (2013-2018)

Figure Colombia COPD Drugs Revenue and Growth Rate (2013-2018)

Table Middle East and Africa COPD Drugs Revenue (Million USD) by Countries (2013-2018)

Table Middle East and Africa COPD Drugs Revenue Market Share by Countries (2013-2018)

Figure Middle East and Africa COPD Drugs Revenue Market Share by Countries (2013-2018)

Figure Middle East and Africa COPD Drugs Revenue Market Share by Countries in 2017

Figure Saudi Arabia COPD Drugs Revenue and Growth Rate (2013-2018)

Figure UAE COPD Drugs Revenue and Growth Rate (2013-2018)

Figure Egypt COPD Drugs Revenue and Growth Rate (2013-2018)

Figure Nigeria COPD Drugs Revenue and Growth Rate (2013-2018)

Figure South Africa COPD Drugs Revenue and Growth Rate (2013-2018)

Table Global COPD Drugs Revenue (Million USD) by Type (2013-2018)

Table Global COPD Drugs Revenue Share by Type (2013-2018)

Figure Global COPD Drugs Revenue Share by Type (2013-2018)

Figure Global COPD Drugs Revenue Share by Type in 2017

Table Global COPD Drugs Revenue Forecast by Type (2018-2023)

Figure Global COPD Drugs Market Share Forecast by Type (2018-2023)

Figure Global Bronchodilators Revenue Growth Rate (2013-2018)

Figure Global PDE-4 Inhibitors Revenue Growth Rate (2013-2018)

Figure Global Steroids Revenue Growth Rate (2013-2018)

Figure Global Combination Therapies Revenue Growth Rate (2013-2018)

Figure Global Others Revenue Growth Rate (2013-2018)

Table Global COPD Drugs Revenue by Application (2013-2018)

Table Global COPD Drugs Revenue Share by Application (2013-2018)

Figure Global COPD Drugs Revenue Share by Application (2013-2018)

Figure Global COPD Drugs Revenue Share by Application in 2017

Table Global COPD Drugs Revenue Forecast by Application (2018-2023)

Figure Global COPD Drugs Market Share Forecast by Application (2018-2023)

Figure Global Hospitals Revenue Growth Rate (2013-2018)

Figure Global Clinics Revenue Growth Rate (2013-2018)

Figure Global Others Revenue Growth Rate (2013-2018)

Figure Global COPD Drugs Revenue (Million USD) and Growth Rate Forecast (2018 -2023)

Table Global COPD Drugs Revenue (Million USD) Forecast by Regions (2018-2023)

Figure Global COPD Drugs Revenue Market Share Forecast by Regions (2018-2023)

Figure North America COPD Drugs Revenue Market Forecast (2018-2023)

Figure Europe COPD Drugs Revenue Market Forecast (2018-2023)

Figure Asia-Pacific COPD Drugs Revenue Market Forecast (2018-2023)

Figure South America COPD Drugs Revenue Market Forecast (2018-2023)

Figure Middle East and Africa COPD Drugs Revenue Market Forecast (2018-2023)



【レポートのキーワード】

COPD薬、気管支拡張薬、PDE-4阻害剤、ステロイド、併用療法、その他、病院、診療所、その他

★調査レポート[COPD薬の世界市場:メーカー別、地域別、種類別、用途別、市場予測(~2023)] (コード:GIR8101467)販売に関する免責事項を必ずご確認ください。
★調査レポート[COPD薬の世界市場:メーカー別、地域別、種類別、用途別、市場予測(~2023)]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆